Kleefstra syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:261494OMIM:610253Q87.8
Who is this for?
Show terms as
15Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Kleefstra syndrome (also known as 9q34 deletion syndrome or 9q subtelomeric deletion syndrome) is a rare genetic neurodevelopmental disorder characterized primarily by intellectual disability, childhood hypotonia (low muscle tone), and a distinctive facial appearance. The condition is caused either by a microdeletion of the 9q34.3 chromosomal region or by loss-of-function mutations in the EHMT1 gene (euchromatic histone methyltransferase 1), which encodes a histone methyltransferase important for normal brain development and function. The syndrome affects multiple body systems. Neurological features include moderate to severe intellectual disability, speech and language delay (with expressive language often more severely affected), and behavioral characteristics such as autism spectrum features, apathy, and intermittent aggression. Seizures occur in a significant proportion of patients. The characteristic facial features include microcephaly, flat midface, hypertelorism, arched eyebrows, short nose with anteverted nares, everted lower lip, and a protruding tongue. Congenital heart defects are present in approximately 30-50% of individuals, with a range of structural anomalies reported. Other features may include renal and urogenital anomalies, hearing loss, obesity, and sleep disturbances. Some patients experience a regression-like phenotype in adolescence or adulthood, characterized by severe apathy, catatonia-like features, and behavioral deterioration. There is currently no cure or disease-specific treatment for Kleefstra syndrome. Management is supportive and multidisciplinary, involving early intervention programs, speech and occupational therapy, behavioral support, and monitoring for associated complications such as cardiac defects, epilepsy, and sleep apnea. Psychiatric symptoms, including catatonia-like episodes, may require careful pharmacological management. Regular developmental assessments and screening for comorbidities are essential components of long-term care.

Clinical phenotype terms— hover any for plain English:

Exaggerated cupid's bowHP:0002263Tented upper lip vermilionHP:0010804Thickened helicesHP:0000391
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Kleefstra syndrome.

View clinical trials →

No actively recruiting trials found for Kleefstra syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Kleefstra syndrome community →

Specialists

15 foundView all specialists →
TK
Tjitske Kleefstra
Specialist
5 Kleefstra syndrome publications
AB
Arianne Bouman
Specialist
4 Kleefstra syndrome publications
DR
Dmitrijs Rots
Specialist
3 Kleefstra syndrome publications
JK
Joost Kummeling
Specialist
3 Kleefstra syndrome publications
ZF
Zoe Frazier
Specialist
2 Kleefstra syndrome publications
TD
Tanja Zdolsek Draksler
Specialist
2 Kleefstra syndrome publications
DM
Donatella Milani
Specialist
2 Kleefstra syndrome publications
ZF
Zoë Frazier
Specialist
2 Kleefstra syndrome publications
HO
Hailey Osika
Specialist
2 Kleefstra syndrome publications
MQ
Meg Quinn
Specialist
2 Kleefstra syndrome publications
MH
Max A Horlbeck
BOSTON, MA
Specialist
2 Kleefstra syndrome publications
AO
Anne O'Donnell-Luria
Specialist
2 Kleefstra syndrome publications
JK
Joe Kossowsky
Specialist
2 Kleefstra syndrome publications
KD
Kira A Dies
BOSTON, MA
Specialist
3 Kleefstra syndrome publications
SV
Sunil K Vasireddi
MADISON, WI
Specialist
2 Kleefstra syndrome publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Kleefstra syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Kleefstra syndromeForum →

No community posts yet. Be the first to share your experience with Kleefstra syndrome.

Start the conversation →

Latest news about Kleefstra syndrome

No recent news articles for Kleefstra syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Kleefstra syndrome

What is Kleefstra syndrome?

Kleefstra syndrome (also known as 9q34 deletion syndrome or 9q subtelomeric deletion syndrome) is a rare genetic neurodevelopmental disorder characterized primarily by intellectual disability, childhood hypotonia (low muscle tone), and a distinctive facial appearance. The condition is caused either by a microdeletion of the 9q34.3 chromosomal region or by loss-of-function mutations in the EHMT1 gene (euchromatic histone methyltransferase 1), which encodes a histone methyltransferase important for normal brain development and function. The syndrome affects multiple body systems. Neurological f

How is Kleefstra syndrome inherited?

Kleefstra syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Kleefstra syndrome typically begin?

Typical onset of Kleefstra syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Kleefstra syndrome?

15 specialists and care centers treating Kleefstra syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.